Tag: pharmaceuticals
-
New Faster Antibiotic Shown Effective for Skin Infections
A clinical trial found an antibiotic tablet designed to work faster than existing oral drugs worked as well as the current drugs to treat bacterial skin infections, including those resistant to current antibiotics. The results of the trial testing the new tedizolid phosphate against the current linezolid appear in today’s issue of the Journal of…
-
Asthma Drug Reveals Potential as Diabetes, Obesity Treatment
A drug long prescribed for asthma and canker sores has been shown in tests on mice to reverse obesity and diabetes. Researchers from University of Michigan in Ann Arbor, and labs in California and Australia, published their findings yesterday online in the journal Nature Medicine (paid subscription required). Alan Saltiel, director of Michigan’s Life Sciences…
-
FDA Grants Accelerated Multiple Myeloma Drug Approval
The U.S. Food and Drug Administration approved pomalidomide to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs. Pomalidomide is marketed under the brand name Pomalyst by the pharmaceutical company Celgene Corporation in Summit, New Jersey. Multiple myeloma is a blood cancer that affects mainly older adults and arises…
-
No Disability Improvement Seen from Clot Device After Stroke
A clinical trial shows devices inserted into an artery after a stroke to remove a blood clot, used with clot-dissolving drugs, do not improve chances of living independently after 90 days compared to the use of drugs alone. The results of the study, funded by National Institute of Neurological Disorders and Stroke, part of the…
-
Nanotech Capsule Delivers Cancer Drugs, Spares Healthy Cells
Engineers at University of California in Los Angeles and University of Southern California developed tiny degradable capsules that can deliver cancer treatments directly to tumors, sparing healthy cells from damage. The team led by UCLA professor Yi Tang published its findings online in the journal Nano Today (paid subscription required). Tang (pictured left) and colleagues…
-
Janssen R&D Opens Lab Space to Individual Entrepreneurs
Janssen Labs at San Diego, part of Janssen Research and Development and the pharmaceutical company Johnson & Johnson, is expanding its open laboratory facilities to individual life science entrepreneurs to conduct early stage research. The facility, open for a year, is already home to 18 start-up companies in the life sciences. Janssen Labs is housed…
-
Clinical Trials To Test More Tamiflu Effects, Plasma on Flu
National Institutes of Health plans three new clinical trials of influenza therapies, two trials involving the current flu drug oseltamivir, and a third trial testing plasma enriched with anti-influenza antibodies. The clinical studies, for which NIH is seeking volunteers, are being held at NIH in Bethesda, Maryland and at 36 other sites elsewhere in the…
-
Pfizer Spins Off Animal Health Unit, Raises $2.2B in IPO
The pharmaceutical company Pfizer Inc. in New York created a new enterprise, Zoetis, from its former animal health division. The new company raised $2.2 billion in its initial public offering, and will trade on the New York Stock exchange under the symbol ZTS. Zoetis, based in Madison, New Jersey, discovers and develops veterinary vaccines and…
-
Weill Cornell, N.Y. Hospital Open Precision Medicine Center
Weill Cornell Medical College and New York-Presbyterian Hospital are opening a medical research and clinical center in New York to deliver targeted, individualized treatments based on each patient’s genetic profile. The Institute for Precision Medicine, as the new center is called, will conduct genetic research to develop new therapies for testing in clinical trials, while…
-
FDA Approves Acute Migraine Treatment Patch System
The U.S. Food and Drug Administration approved a battery-powered patch system made by Nupathe Inc. of Conshohocken, Pennsylvania for the treatment of migraine. The patch, marketed as Zecuity, is a single-use system that delivers the drug sumatriptan, and was approved by FDA for treating migraine headaches and nausea after symptoms occur, known as acute treatments.…